Neurology Perspectives,
Год журнала:
2021,
Номер
1, С. S16 - S24
Опубликована: Дек. 1, 2021
SARS-CoV-2
infection
frequently
causes
neurological
symptoms.
Cognitive
alterations
are
among
the
most
frequent
symptoms,
and
may
persist
beyond
acute
phase
of
infection.
Archives of Clinical Neuropsychology,
Год журнала:
2024,
Номер
unknown
Опубликована: Июнь 8, 2024
Abstract
Objective
Although
Coronavirus
disease
2019
(COVID-19)
is
primarily
a
respiratory
infectious
disease,
it
has
also
been
associated
with
wide
range
of
other
clinical
manifestations.
It
widely
accepted
in
the
scientific
community
that
many
patients
after
recovery
continue
to
experience
COVID-19-related
symptoms,
including
cognitive
impairment.
The
aim
this
systematic
review
was
investigate
profile
long-COVID
syndrome.
Methods
A
search
empirical
studies
conducted
through
PubMed/Medline
and
Scopus
electronic
databases.
Cross-sectional
longitudinal
published
between
2020
2023
were
included.
Results
Of
516
assessed
for
eligibility,
36
met
inclusion
criteria.
All
included
support
presence
persistent
changes
COVID-19
disease.
Executive
function,
memory,
attention,
processing
speed
appear
be
domains
are
predominantly
syndrome,
whereas
language
an
area
not
sufficiently
investigated.
Conclusions
In
review,
high
frequency
impairment
evident.
If
we
consider
functioning
affects
our
ability
live
independently
key
determinant
quality
life,
imperative
precisely
define
those
factors
may
induce
survivors,
ultimate
goal
early
diagnosis
and,
consequently,
development
targeted
rehabilitation
interventions
address
them.
Bioengineering,
Год журнала:
2025,
Номер
12(3), С. 295 - 295
Опубликована: Март 14, 2025
Because
of
their
nature,
biomarkers
for
neuropsychiatric
diseases
were
out
the
reach
medical
diagnostic
technology
until
past
few
decades.
In
recent
years,
confluence
greater,
affordable
computer
power
with
need
more
efficient
diagnoses
and
treatments
has
increased
interest
in
possibility
discovery.
This
review
will
focus
on
progress
made
over
ten
years
regarding
search
electroencephalographic
diseases.
includes
algorithms
methods
analysis,
machine
learning,
quantitative
electroencephalography
as
applied
to
neurodegenerative
neurodevelopmental
well
traumatic
brain
injury
COVID-19.
Our
findings
suggest
that
there
is
a
consensus
among
researchers
classification
most
suit
this
field;
slight
disconnection
between
development
increasingly
sophisticated
analysis
what
they
actually
be
use
clinical
setting;
finally,
are
favored
type
field
caveats.
The
main
goal
state-of-the-art
provide
reader
general
panorama
state
art
field.
JAMA Network Open,
Год журнала:
2025,
Номер
8(4), С. e255532 - e255532
Опубликована: Апрель 17, 2025
Importance
The
COVID-19
pandemic
has
been
associated
with
risk
factors
for
cognitive
decline,
such
as
bereavement
and
SARS-CoV-2
infection.
Objective
To
examine
whether
the
pandemic-related
exposures
are
function
among
middle-aged
women.
Design,
Setting,
Participants
This
cohort
study
analyzed
data
from
Nurses’
Health
Study
II,
an
ongoing
of
registered
nurses
in
US.
present
focused
on
women
aged
51
to
76
years
who
completed
2
8
objective
assessments
both
prior
(October
1,
2014,
February
29,
2020)
during
(March
2020,
September
30,
2022).
Statistical
analyses
were
performed
January
2023
2025.
Exposure
pandemic.
Main
Outcomes
Measures
Two
standardized
(ie,
z
-scored)
composite
scores
(psychomotor
speed
attention,
learning
working
memory)
a
global
score
constituted
primary
outcomes.
Higher
indicated
better
function.
Cognitive
was
assessed
using
Cogstate
Brief
Battery,
computer-administered
test
battery.
every
6
12
months.
Results
A
total
5191
(mean
[SD]
age
at
first
assessment,
63.0
[4.8]
years)
prepandemic
during-pandemic
measures,
contributing
23
678
assessments.
After
adjustment
educational
level
participants
their
parents,
practice
effects,
comorbidities
(eg,
diabetes,
hypertension),
no
difference
observed
between
taken
vs
before
attention:
β
=
−0.01
SD
[95%
CI,
−0.05
0.02
SD];
memory:
0.00
−0.03
0.03
score:
SD]).
Among
4456
responded
substudy
surveys
about
events),
those
history
infection
(164
[3.7%])
or
post–COVID-19
conditions
(PCC;
62
[1.4%]),
median
(IQR)
20.0
(18.5-22.1)
months
after
initial
infection,
had
reduced
compared
without
PCC;
however,
these
differences
did
not
reach
statistical
significance,
wide
CIs
suggested
considerable
uncertainty.
Conclusions
Relevance
found
that
events
decline
up
2.5
onset
Future
studies
needed
long-term
implications
PCC
Neurology Perspectives,
Год журнала:
2021,
Номер
1, С. S16 - S24
Опубликована: Дек. 1, 2021
SARS-CoV-2
infection
frequently
causes
neurological
symptoms.
Cognitive
alterations
are
among
the
most
frequent
symptoms,
and
may
persist
beyond
acute
phase
of
infection.